Back to Search Start Over

Management of Unresectable Localized Pelvic Bone Sarcomas: Current Practice and Future Perspectives.

Authors :
Soares do Brito, Joaquim
Esperança-Martins, Miguel
Abrunhosa-Branquinho, André
Melo-Alvim, Cecilia
Lopes-Brás, Raquel
Janeiro, João
Lopez-Presa, Dolores
Fernandes, Isabel
Portela, José
Costa, Luis
Source :
Cancers; May2022, Vol. 14 Issue 10, p2546-N.PAG, 24p
Publication Year :
2022

Abstract

Simple Summary: Some locally advanced pelvic bone tumors are deemed unresectable and, as such, not suitable for curative surgery. In this setting, treatment options are generally limited and not unanimous, with decisions being made on an individual basis after multidisciplinary discussion. Ultimately, and notwithstanding the bright prospects raised by novel therapeutic approaches, treatment should be patient-tailored, weighing a panoply of patient- and tumor-related factors. Bone sarcomas (BS) are rare mesenchymal tumors usually located in the extremities and pelvis. While surgical resection is the cornerstone of curative treatment, some locally advanced tumors are deemed unresectable and hence not suitable for curative intent. This is often true for pelvic sarcoma due to anatomic complexity and proximity to vital structures, making treatment options for these tumors generally limited and not unanimous, with decisions being made on an individual basis after multidisciplinary discussion. Several studies have been published in recent years focusing on innovative treatment options for patients with locally advanced sarcoma not amenable to local surgery. The present article reviews the evidence regarding the treatment of patients with locally advanced and unresectable pelvic BS, with the goal of providing an overview of treatment options for the main BS histologic subtypes involving this anatomic area and exploring future therapeutic perspectives. The management of unresectable localized pelvic BS represents a major challenge and is hampered by the lack of comprehensive and standardized guidelines. As such, the optimal treatment needs to be individually tailored, weighing a panoply of patient- and tumor-related factors. Despite the bright prospects raised by novel therapeutic approaches, the role of each treatment option in the therapeutic armamentarium of these patients requires solid clinical evidence before becoming fully established. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20726694
Volume :
14
Issue :
10
Database :
Complementary Index
Journal :
Cancers
Publication Type :
Academic Journal
Accession number :
157147451
Full Text :
https://doi.org/10.3390/cancers14102546